Ascendis Pharma A/S announced that it has granted Novo Nordisk A/S an exclusive worldwide license to the TransCon technology platform to develop, manufacture and commercialize Novo Nordisk proprietary ...

In a report released yesterday, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Ascendis Pharma (ASND – Research ...

Ascendis Pharma will license its TransCon technology to Novo to develop therapies for metabolic and cardiovascular diseases.

Portfolio Receipts growth of 15% to $735 million; Royalty Receipts growth of 15%Net cash provided by operating activities of $704 millionCapital Deployment of approximately $1.2 billion Raising full ...

In a report released today, Peter Welford from Jefferies maintained a Sell rating on Novo Nordisk (0QIU – Research Report), with a price ...

STAT Plus: Medicare Advantage insurers ramped up use of technology to deny claims, Senate investigation shows ...

Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 27,123.90 Crore) operating in Pharmaceuticals sector. Gland Pharma Ltd. key Products/Revenue ...

Three gangsters entered a West Delhi showroom in broad daylight yesterday, gave the owner an extortion note with an amount written on it, fired multiple times in the air to drive home their ...

At least two polling sites in the US election battleground state of Georgia were briefly evacuated on Tuesday after fake bomb threats that election officials in the state blamed on Russian agents.

Michigan Pension Fund Diversifies Crypto Holdings, Buys $10M in Ether ETFs ...